IDenta Corp (IDTA)
0.50
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
IDenta Profit Margin (Quarterly): 22.13% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 22.13% |
March 31, 2024 | 39.92% |
June 30, 2023 | -40.50% |
March 31, 2023 | -11.03% |
December 31, 2022 | 43.58% |
September 30, 2022 | 5.84% |
June 30, 2022 | 1.98% |
March 31, 2022 | -16.72% |
December 31, 2021 | -6.94% |
September 30, 2021 | -13.66% |
June 30, 2021 | 29.14% |
March 31, 2021 | 19.63% |
December 31, 2020 | -41.42% |
September 30, 2020 | 57.09% |
Date | Value |
---|---|
June 30, 2020 | 19.45% |
March 31, 2020 | 31.85% |
December 31, 2019 | -19.00% |
September 30, 2019 | 11.78% |
June 30, 2019 | 11.11% |
March 31, 2019 | -1.54% |
December 31, 2018 | 30.14% |
September 30, 2018 | 37.61% |
June 30, 2018 | 0.91% |
March 31, 2018 | 8.01% |
December 31, 2017 | -39.80% |
September 30, 2017 | -60.16% |
June 30, 2017 | -74.12% |
March 31, 2017 | -5.53% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-41.42%
Minimum
Dec 2020
57.09%
Maximum
Sep 2020
7.14%
Average
5.84%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
InspireMD Inc | -454.8% |
IR-Med Inc | -- |
Pluri Inc | -5.97K% |
BiomX Inc | -- |
Raphael Pharmaceutical Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 28.44% |
Return on Assets | 9.63% |
Return on Invested Capital | 14.80% |
Gross Profit Margin (Quarterly) | 69.38% |
Operating Margin (Quarterly) | 20.10% |
Return on Net Operating Assets | 12.71% |